Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Assembly Biosciences (NQ: ASMB )

5.080 USD -0.450 (-8.14%)
Official Closing Price Updated: 7:49 PM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,390,200
Open 5.210
Bid (Size) 5.110 (2)
Ask (Size) 5.140 (1)
Prev. Close 5.530
Today's Range 5.070 - 5.540
52wk Range 4.780 - 27.84
Shares Outstanding 20,550,718
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of Triple Combination Therapy for the Treatment of Chronic Hepatitis B Virus
From GlobeNewswire News Releases
Assembly Biosciences Reports Fourth Quarter and Year End 2020 Financial Results and Recent Highlights
From GlobeNewswire News Releases

Performance

YTD
-15.89%
-15.89%
1 Month
-10.09%
-10.09%
3 Month
-15.33%
-15.33%
6 Month
-76.62%
-76.62%
1 Year
-71.36%
-71.36%

More News

Read More
Assembly Biosciences Updates Pipeline Strategy, Focusing on Finite and Curative Therapies for Chronic Hepatitis B Virus Infection
From GlobeNewswire News Releases
Assembly Bio Announces Upcoming Investor Events
From GlobeNewswire News Releases
Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
Assembly Biosciences to Wind-Down Microbiome Program
From GlobeNewswire News Releases
Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
Assembly Biosciences Appoints Nicole S. White, PhD, as Senior Vice President of Pharmaceutical Development and Manufacturing
From GlobeNewswire News Releases
Assembly Biosciences and Door Pharmaceuticals Sign Collaboration and Option Agreement to Develop a Novel Class of HBV Core Protein Modulators
From GlobeNewswire News Releases
Assembly Biosciences Presents Data from HBV Core Inhibitor Programs in Poster Sessions at the 2020 AASLD The Liver Meeting Digital Experience™
From GlobeNewswire News Releases
Assembly Bio/Arbutus Bio Start Testing Vebicorvir/AB-729 Triplet Therapy In HBV Infection
Tags Biotech ASMB General
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.